Fig. 16From: Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenalFDA-approved protease inhibitors, decahydroisoquinoline scaffold-bearing adducts, and natural product-based 3Clpro inhibitorsBack to article page